WCM Investment Management
WST icon

WCM Investment Management’s West Pharmaceutical WST Stock Holding History

WCM Investment Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,236,059
Closed -$311M – 220
2022
Q3 		$311M Buy
1,236,059
+134,020
+12% +$40.8M 1.11% 28
2022
Q2 		$330M Sell
1,102,039
-424,442
-28% -$138M 1.18% 26
2022
Q1 		$627M Buy
1,526,481
+11,655
+0.8% +$4.56M 1.75% 15
2021
Q4 		$710M Buy
1,514,826
+72,006
+5% +$31M 1.6% 17
2021
Q3 		$613M Sell
1,442,820
-237,453
-14% -$100M 1.42% 18
2021
Q2 		$603M Buy
1,680,273
+7,599
+0.5% +$2.51M 1.53% 16
2021
Q1 		$471M Buy
1,672,674
+59,302
+4% +$17M 1.29% 15
2020
Q4 		$457M Buy
1,613,372
+240,412
+18% +$67.5M 1.24% 15
2020
Q3 		$377M Sell
1,372,960
-186,749
-12% -$49.4M 1.32% 14
2020
Q2 		$354M Buy
1,559,709
+148,890
+11% +$29.3M 1.36% 13
2020
Q1 		$215M Buy
1,410,819
+72,700
+5% +$11.2M 1.19% 18
2019
Q4 		$201M Sell
1,338,119
-15,376
-1% -$2.24M 1.08% 16
2019
Q3 		$192M Buy
1,353,495
+61,308
+5% +$8.44M 1.15% 14
2019
Q2 		$162M Buy
1,292,187
+170,071
+15% +$20.1M 1.01% 19
2019
Q1 		$124M Buy
1,122,116
+13,448
+1% +$1.4M 0.86% 24
2018
Q4 		$109M Buy
1,108,668
+72,634
+7% +$7.88M 0.97% 22
2018
Q3 		$128M Buy
1,036,034
+350,614
+51% +$39.3M 1.15% 16
2018
Q2 		$68.1M Buy
685,420
+117,433
+21% +$10.8M 0.7% 29
2018
Q1 		$50.1M Buy
+567,987
New +$53.1M 0.47% 31

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

WCM Investment Management's WST Position: Q4 2022 in Review

WCM Investment Management sold out of West Pharmaceutical (WST) in Q4 2022, closing a stake of 1,236,059 shares — an estimated $311M sold.

WCM Investment Management first reported a position in WST in Q1 2018 and held it in 19 quarters. The position peaked at $710M in Q4 2021. 637 funds tracked by Wall St. Rank hold WST as of Q4 2022.

  • WCM Investment Management reported no remaining West Pharmaceutical position as of Q4 2022 after selling out during the quarter.
  • WCM Investment Management sold 1,236,059 West Pharmaceutical shares in Q4 2022, an estimated $311M.
  • WCM Investment Management first reported a position in West Pharmaceutical in Q1 2018 and held it in 19 quarters.
  • WCM Investment Management's West Pharmaceutical position peaked at $710M in Q4 2021.
  • 637 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2022.

Based on WCM Investment Management's 13F filing for Q4 2022, filed 7 Feb 2023.